The Effect of Alcohol Drinking on Metabolic Syndrome and Obesity in Koreans: Big Data Analysis
Abstract
:1. Introduction
2. Materials and Methods
2.1. The NHIS Database and NHIS Health Checkup Program
2.2. Subjects
2.3. Study Methods
2.4. Statistical Methods
3. Results
3.1. General Characteristics of Subjects
3.2. Prevalence of the Components of Metabolic Syndrome and Obesity According to Alcohol Consumption
3.3. Odds Ratios of Metabolic Syndrome and Obesity According to Alcohol Consumption
3.4. Odds Ratios of Metabolic Syndrome and Obesity According to Age in Men
3.5. Odds Ratios of Metabolic Syndrome and Obesity According to Age in Women
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization. Alcohol, Total per Capita (15+) Consumption in Litres of Pure Alcohol). Available online: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/total-(recorded-unrecorded)-alcohol-per-capita-(15-)-consumption (accessed on 13 April 2022).
- Hendriks, H. Alcohol and Human Health: What Is the Evidence? Annu. Rev. Food Sci. Technol. 2020, 11, 1–21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Korean Statistical Information Service (KOSIS). Available online: https://kosis.kr/statHtml/statHtml.do?orgId=350&tblId=DT_35007_N136&vw_cd=MT_ZTITLE&list_id=350_35007_BC&scrId=&seqNo=&lang_mode=ko&obj_var_id=&itm_id=&conn_path=MT_ZTITLE&path=%252FstatisticsList%252FstatisticsListIndex.do (accessed on 19 March 2022).
- Nam, G.E.; Kim, Y.H.; Han, K.; Jung, J.H.; Rhee, E.J.; Lee, W.Y.; Obesity Fact Sheet of the Korean Society for the Study of Obesity. Obesity Fact Sheet in Korea, 2020: Prevalence of Obesity by Obesity Class from 2009 to 2018. J. Obes. Metab. Syndr. 2021, 30, 141–148. [Google Scholar] [CrossRef] [PubMed]
- Sun, K.; Ren, M.; Liu, D.; Wang, C.; Yang, C.; Yan, L. Alcohol consumption and risk of metabolic syndrome: A meta-analysis of prospective studies. Clin. Nutr. (Edinb. Scotl.) 2014, 33, 596–602. [Google Scholar] [CrossRef]
- Kim, B.J.; Kim, B.S.; Kang, J.H. Alcohol consumption and incidence of metabolic syndrome in Korean men. A 3-year follow-up study. Circ. J. Off. J. Jpn. Circ. Soc. 2012, 76, 2363–2371. [Google Scholar] [CrossRef] [Green Version]
- Baik, I.; Shin, C. Prospective study of alcohol consumption and metabolic syndrome. Am. J. Clin. Nutr. 2008, 87, 1455–1463. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Traversy, G.; Chaput, J.P. Alcohol Consumption and Obesity: An Update. Curr. Obes. Rep. 2015, 4, 122–130. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tanaka, H.; Ikai, E.; Yamada, Y. Genetic polymorphisms in alcohol metabolizing enzymes as related to sensitivity to alcohol-induced health effects. Environ. Health Prev. Med. 1997, 1, 193–200. [Google Scholar] [CrossRef] [Green Version]
- Harada, S. Classification of alcohol metabolizing enzymes and polymorphisms—Specificity in Japanese. Nihon Arukoru Yakubutsu Igakkai Zasshi 2001, 36, 85–106. [Google Scholar]
- Alcohol Research: Current Reviews Editorial Staff. Drinking patterns and their definitions. Alcohol. Res. 2018, 39, 17–18. [Google Scholar]
- Lee, S.; Kim, J.S.; Jung, J.G.; Oh, M.K.; Chung, T.H.; Kim, J. Korean Alcohol Guidelines for Moderate Drinking Based on Facial Flushing. Korean J. Fam. Med. 2019, 40, 204–211. [Google Scholar] [CrossRef] [Green Version]
- Lee, S.W.; Jang, S.I. Association of Alcohol Drinking Patterns with Metabolic Syndrome and Its Components in Korean Adults: The Korea National Health and Nutrition Examination Survey 2016–2018. Int. J. Environ. Res. Public Health 2021, 18, 6433. [Google Scholar] [CrossRef] [PubMed]
- Song, S.O.; Jung, C.H.; Song, Y.D.; Park, C.Y.; Kwon, H.S.; Cha, B.S.; Park, J.Y.; Lee, K.U.; Ko, K.S.; Lee, B.W. Background and data configuration process of a nationwide population-based study using the Korean national health insurance system. Diabetes Metab. J. 2014, 38, 395–403. [Google Scholar] [CrossRef] [PubMed]
- Song, Y.J. The South Korean Health Care System. Jpn. Med. Assoc. J. 2009, 52, 206–209. [Google Scholar]
- Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.; Krauss, R.M.; Savage, P.J.; Smith, S.C.; et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112, 2735–2752. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Seo, M.H.; Lee, W.Y.; Kim, S.S.; Kang, J.H.; Kang, J.H.; Kim, K.K.; Kim, B.Y.; Kim, Y.H.; Kim, W.J.; Kim, E.M.; et al. 2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea. J. Obes. Metab. Syndr. 2019, 28, 40–45. [Google Scholar] [CrossRef] [PubMed]
- De Oliveira, E.; Silva, E.R.; Foster, D.; McGee Harper, M.; Seidman, C.E.; Smith, J.D.; Breslow, J.L.; Brinton, E.A. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 2000, 102, 2347–2352. [Google Scholar] [CrossRef] [PubMed]
- Chan, A.W. Racial differences in alcohol sensitivity. Alcohol Alcohol. 1986, 21, 93–104. [Google Scholar]
- Husain, K.; Ansari, R.A.; Ferder, L. Alcohol-induced hypertension: Mechanism and prevention. World J. Cardiol. 2014, 6, 245–252. [Google Scholar] [CrossRef] [PubMed]
- Van de Wiel, A. Diabetes mellitus and alcohol. Diabetes/Metab. Res. Rev. 2004, 20, 263–267. [Google Scholar] [CrossRef]
- Klop, B.; do Rego, A.T.; Cabezas, M.C. Alcohol and plasma triglycerides. Curr. Opin. Lipidol. 2013, 24, 321–326. [Google Scholar] [CrossRef]
- Choi, I.G.; Kee, B.S.; Son, H.G.; Ham, B.J.; Yang, B.H.; Kim, S.H.; Lee, J.S.; Son, B.K.; Lee, B.Y.; Lee, S.Y.; et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenase, dopamine and serotonin transporters in familial and non-familial alcoholism. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 2006, 16, 123–128. [Google Scholar] [CrossRef] [PubMed]
- Mizoi, Y.; Tatsuno, Y.; Adachi, J.; Kogame, M.; Fukunaga, T.; Fujiwara, S.; Hishida, S.; Ijiri, I. Alcohol sensitivity related to polymorphism of alcohol-metabolizing enzymes in Japanese. Pharmacol. Biochem. Behav. 1983, 18 (Suppl. S1), 127–133. [Google Scholar] [CrossRef]
- Wannamethee, S.G.; Shaper, A.G. Alcohol, body weight, and weight gain in middle-aged men. Am. J. Clin. Nutr. 2003, 77, 1312–1317. [Google Scholar] [CrossRef] [Green Version]
- Sakurai, Y.; Umeda, T.; Shinchi, K.; Honjo, S.; Wakabayashi, K.; Todoroki, I.; Nishikawa, H.; Ogawa, S.; Katsurada, M. Relation of total and beverage-specific alcohol intake to body mass index and waist-to-hip ratio: A study of self-defense officials in Japan. Eur. J. Epidemiol. 1997, 13, 893–898. [Google Scholar] [CrossRef]
- Duncan, B.B.; Chambless, L.E.; Schmidt, M.I.; Folsom, A.R.; Szklo, M.; Crouse, J.R., 3rd; Carpenter, M.A. Association of the waist-to-hip ratio is different with wine than with beer or hard liquor consumption. Atherosclerosis Risk in Communities Study Investigators. Am. J. Epidemiol. 1995, 142, 1034–1038. [Google Scholar] [CrossRef] [PubMed]
- Dallongeville, J.; Marécaux, N.; Ducimetière, P.; Ferrières, J.; Arveiler, D.; Bingham, A.; Ruidavets, J.B.; Simon, C.; Amouyel, P. Influence of alcohol consumption and various beverages on waist girth and waist-to-hip ratio in a sample of French men and women. Int. J. Obes. Relat. Metab. Disord. J. Int. Assoc. Study Obes. 1998, 22, 1178–1183. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Stockwell, T.; Donath, S.; Cooper-Stanbury, M.; Chikritzhs, T.; Catalano, P.; Mateo, C. Under-reporting of alcohol consumption in household surveys: A comparison of quantity-frequency, graduated-frequency and recent recall. Addiction 2004, 99, 1024–1033. [Google Scholar] [CrossRef]
- De Castro, J.M.; Orozco, S. Moderate alcohol intake and spontaneous eating patterns of humans: Evidence of unregulated supplementation. Am. J. Clin. Nutr. 1990, 52, 246–253. [Google Scholar] [CrossRef]
Variables | Male | Female | p-Value |
---|---|---|---|
Total number | 14,516,804 | 12,474,625 | |
Age (year) | 47.71 ± 13.7 | 50.19 ± 14.37 | <0.0001 |
20 to 39 | 4,415,937 (30.42) | 2,769,241 (22.20) | <0.0001 |
40 to 64 | 8,296,562 (57.15) | 7,659,563 (61.40) | <0.0001 |
≥65 | 1,804,305 (12.43) | 2,045,821 (16.40) | <0.0001 |
Low-income | 2,105,800 (14.51) | 2,889,503 (23.16) | <0.0001 |
Large city residents | 6,286,419 (43.30) | 5,685,870 (45.58) | <0.0001 |
Past or present smokers | 10,023,308 (69.05) | 669,206 (5.36) | <0.0001 |
Regular exercise | 3,367,994 (23.20) | 2,252,416 (18.06) | <0.0001 |
Height (cm) | 170.53 ± 6.49 | 157.08 ± 6.23 | <0.0001 |
Weight (kg) | 71.26 ± 10.99 | 57.27 ± 8.88 | <0.0001 |
Waist circumference (cm) | 84.29 ± 8.11 | 76.48 ± 9.14 | <0.0001 |
Abdominal obesity | 3,547,448 (24.44) | 2,309,114 (18.51) | <0.0001 |
BMI (kg/m2) | 24.45 ± 3.15 | 23.22 ± 3.46 | <0.0001 |
Obesity (BMI ≥ 25) | 5,853,936 (40.33) | 3,332,743 (26.72) | <0.0001 |
Underweight (BMI < 18.5) | 287,186 (1.98) | 695,849 (5.58) | <0.0001 |
SBP (mm Hg) | 124.23 ± 13.38 | 119.01 ± 14.98 | <0.0001 |
DBP (mm Hg) | 77.68 ± 9.41 | 73.71 ± 9.68 | <0.0001 |
FPG (mg/dL) | 101.42 ± 24.84 | 96.48 ± 20.49 | <0.0001 |
T-C (mg/dL) | 193.64 ± 36.75 | 195.26 ± 37.07 | <0.0001 |
TG (mg/dL) * | 123.55 (123.51–123.59) | 92.24 (92.21–92.27) | <0.0001 |
HDL-C (mg/dL) | 52.09 ± 13.33 | 59.81 ± 14.68 | <0.0001 |
LDL-C (mg/dL) | 113.43 ± 35.97 | 114.15 ± 34.98 | <0.0001 |
Metabolic syndrome | 2,164,785 (14.91) | 1,582,426 (12.69) | <0.0001 |
Drinking | <0.0001 | ||
Nondrinkers | 4,648,007 (32.02) | 8,934,014 (71.62) | |
≤7.0 g/d | 3,194,505 (22.01) | 2,446,858 (19.61) | |
7.1 to 14.0 g/d | 2,306,251 (15.89) | 563,425 (4.52) | |
14.1 to 28.0 g/d | 2,321,398 (15.99) | 347,776 (2.79) | |
≥28.1 g/d | 2,046,643 (14.1) | 182,552 (1.46) | |
Binge drinking † | <0.0001 | ||
No | 13,665,462 (94.14) | 12,272,085 (98.38) | |
Yes | 851,342 (5.86) | 202,540 (1.62) |
Variables | Nondrinkers | ≤7.0 g Per Day | 7.1 to 14.0 g Per Day | 14.1 to 28.0 g Per Day | ≥28.1 g Per Day | p-Value |
---|---|---|---|---|---|---|
Men | ||||||
WC | 23.28 (23.24–23.32) | 21.78 (21.73–21.82) | 24.26 (24.21–24.32) | 26.28 (26.23–26.34) | 29.32 (29.26–29.38) | <0.0001 |
BP | 43.8 (43.78–43.87) | 46.18 (46.13–46.23) | 51.33 (51.27–51.4) | 55.68 (55.62–55.74) | 59.38 (59.31–59.45) | <0.0001 |
FPG | 36.65 (36.6–36.69) | 37.99 (37.93–38.04) | 41.49 (41.43–41.55) | 45.34 (45.28–45.4) | 48.79 (48.72–48.85) | <0.0001 |
HDL-C | 31.11 (31.08–31.15) | 25.42 (25.38–25.47) | 24.42 (24.36–24.47) | 22.94 (22.89–23.00) | 21.81 (21.75–21.86) | <0.0001 |
TG | 40.45 (40.41–40.5) | 39.70 (39.65–39.76) | 44.05 (43.99–44.12) | 47.87 (47.81–47.93) | 51.17 (51.11–51.24) | <0.0001 |
MetS | 14.08 (14.05–14.11) | 13.05 (13.01–13.08) | 14.85 (14.81–14.9) | 16.35 (16.31–16.4) | 18.14 (18.1–18.19) | <0.0001 |
Obesity | 38.41 (38.36–38.45) | 37.35 (37.3–37.41) | 40.76 (40.69–40.82) | 43.24 (43.18–43.31) | 45.53 (45.46–45.6) | <0.0001 |
Women | ||||||
WC | 18.46 (18.44–18.49) | 17.28 (17.24–17.33) | 20.64 (20.54–20.74) | 22.19 (22.06–22.32) | 23.73 (23.56–23.91) | <0.0001 |
BP | 35.38 (35.35–35.41) | 35.90 (35.85–35.96) | 41.48 (41.37–41.59) | 44.99 (44.84–45.13) | 47.75 (47.55–47.95) | <0.0001 |
FPG | 28.44 (28.41–28.47) | 28.84 (28.78–28.89) | 32.85 (32.74–32.97) | 35.28 (35.13–35.42) | 37.11 (36.90–37.31) | <0.0001 |
HDL-C | 38.39 (38.36–38.42) | 30.95 (30.89–31.01) | 29.49 (29.37–29.6) | 28.27 (28.12–28.42) | 27.90 (27.69–28.10) | <0.0001 |
TG | 30.18 (30.15–30.21) | 26.35 (26.29–26.40) | 29.57 (29.46–29.69) | 32.09 (31.94–32.23) | 35.02 (34.82–35.21) | <0.0001 |
MetS | 12.87 (12.85–12.89) | 11.49 (11.45–11.53) | 13.33 (13.25–13.42) | 14.02 (13.91–14.12) | 15.01 (14.86–15.15) | <0.0001 |
Obesity | 26.88 (26.85–26.91) | 24.99 (24.93–25.04) | 28.52 (28.41–28.64) | 29.84 (29.7–29.99) | 30.54 (30.34–30.74) | <0.0001 |
Amount | WC | BP | FPG | HDL-C | TG | MetS | Obesity |
---|---|---|---|---|---|---|---|
Men | |||||||
Nondrinkers | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
≤7.0 g/d | 0.92 (0.91–0.92) | 1.11 (1.1–1.12) | 1.06 (1.06–1.07) | 0.75 (0.75–0.75) | 0.97 (0.97–0.97) | 0.91 (0.90–0.91) | 0.96 (0.96–0.96) |
7.1–14.0 g/d | 1.06 (1.05–1.06) | 1.39 (1.38–1.39) | 1.25 (1.24–1.25) | 0.71 (0.71–0.72) | 1.17 (1.16–1.17) | 1.09 (1.08–1.09) | 1.10 (1.10–1.11) |
14.1–28.0 g/d | 1.18 (1.17–1.18) | 1.67 (1.67–1.68) | 1.47 (1.47–1.48) | 0.66 (0.66–0.66) | 1.36 (1.36,1.37) | 1.25 (1.24–1.25) | 1.22 (1.22–1.23) |
≥28 g/d | 1.37 (1.36–1.37) | 1.96 (1.95–1.97) | 1.70 (1.70–1.71) | 0.62 (0.62–0.62) | 1.56 (1.55–1.56) | 1.42 (1.42–1.43) | 1.34 (1.34–1.35) |
p-value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Women | |||||||
Nondrinkers | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
≤7.0 g/d | 0.89 (0.89–0.89) | 1.03 (1.03–1.04) | 1.02 (1.01–1.02) | 0.68 (0.67–0.68) | 0.77 (0.77–0.77) | 0.76 (0.76–0.77) | 0.89 (0.89–0.89) |
7.1–14.0 g/d | 1.17 (1.16–1.18) | 1.41 (1.40–1.42) | 1.27 (1.26–1.28) | 0.60 (0.59–0.60) | 0.94 (0.93–0.94) | 0.97 (0.96–0.98) | 1.09 (1.08–1.10) |
14.1–28.0 g/d | 1.32 (1.30–1.33) | 1.73 (1.71–1.74) | 1.45 (1.44–1.46) | 0.55 (0.54–0.55) | 1.11 (1.10–1.12) | 1.07 (1.06–1.09) | 1.18 (1.17–1.19) |
≥28 g/d | 1.46 (1.45–1.48) | 2.00 (1.98–2.02) | 1.59 (1.58–1.61) | 0.52 (0.51–0.52) | 1.31 (1.29–1.33) | 1.18 (1.15–1.20) | 1.22 (1.20–1.23) |
p-value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Amount | WC | FPG | BP | HDL-C | TG | MetS | Obesity |
---|---|---|---|---|---|---|---|
Age 20–39 | |||||||
Nondrinkers | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
≤7.0 g/d | 0.92 (0.91–0.93) | 1.00 (0.99–1.00) | 1.04 (1.04–1.05) | 0.70 (0.70–0.71) | 0.94 (0.94–0.95) | 0.82 (0.81–0.83) | 0.96 (0.96–0.97) |
7.1–14.0 g/d | 1.05 (1.05–1.06) | 1.13 (1.13–1.14) | 1.27 (1.27–1.28) | 0.65 (0.64–0.65) | 1.15 (1.15–1.16) | 1.01 (0.99–1.02) | 1.12 (1.11–1.13) |
14.1–28.0 g/d | 1.18 (1.17–1.19) | 1.32 (1.31–1.33) | 1.54 (1.53–1.55) | 0.55 (0.54–0.55) | 1.38 (1.37–1.39) | 1.15 (1.14–1.17) | 1.26 (1.25–1.26) |
≥28 g/d | 1.40 (1.39–1.41) | 1.53 (1.52–1.54) | 1.86 (1.85–1.88) | 0.49 (0.48–0.49) | 1.69 (1.68–1.70) | 1.41 (1.40–1.43) | 1.44 (1.43–1.45) |
p-value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Age 40–64 | |||||||
Nondrinkers | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
≤7.0 g/d | 0.90 (0.90–0.91) | 1.06 (1.06–1.06) | 1.15 (1.14–1.15) | 0.74 (0.74–0.74) | 0.96 (0.96–0.97) | 0.90 (0.90–0.91) | 0.94 (0.93–0.94) |
7.1–14.0 g/d | 1.05 (1.04–1.05) | 1.25 (1.25–1.26) | 1.46 (1.45–1.46) | 0.71 (0.71–0.71) | 1.15 (1.15–1.16) | 1.09 (1.08–1.10) | 1.07 (1.07–1.08) |
14.1–28.0 g/d | 1.17 (1.16–1.17) | 1.48 (1.47–1.48) | 1.76 (1.75–1.77) | 0.66 (0.66–0.67) | 1.33 (1.32–1.33) | 1.25 (1.24–1.25) | 1.17 (1.16–1.17) |
≥28 g/d | 1.37 (1.36–1.38) | 1.72 (1.71–1.73) | 2.05 (2.04–2.06) | 0.64 (0.63–0.64) | 1.50 (1.49–1.50) | 1.43 (1.43–1.44) | 1.28 (1.28–1.29) |
p-value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Age ≥ 65 | |||||||
Nondrinkers | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
≤7.0 g/d | 0.97 (0.96–0.97) | 1.03 (1.02–1.04) | 1.14 (1.13–1.15) | 0.78 (0.77–0.79) | 0.95 (0.95–0.96) | 0.92 (0.92–0.93) | 0.99 (0.98–1.00) |
7.1–14.0 g/d | 1.10 (1.08–1.11) | 1.17 (1.15–1.18) | 1.41 (1.40–1.43) | 0.71 (0.70–0.72) | 1.04 (1.03–1.05) | 1.00 (0.99–1.02) | 1.08 (1.07–1.10) |
14.1–28.0 g/d | 1.20 (1.19–1.22) | 1.28 (1.27–1.29) | 1.58 (1.56–1.60) | 0.66 (0.65–0.67) | 1.08 (1.07–1.10) | 1.04 (1.03–1.05) | 1.15 (1.14–1.16) |
≥28 g/d | 1.22 (1.21–1.24) | 1.42 (1.39–1.42) | 1.66 (1.64–1.68) | 0.55 (0.55–0.56) | 1.10 (1.09–1.11) | 1.01 (0.99–1.02) | 1.08 (1.07–1.09) |
p-value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Amount | WC | FPG | BP | HDL-C | TG | MetS | Obesity |
---|---|---|---|---|---|---|---|
Age 20–39 | |||||||
Nondrinkers | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
≤7.0 g/d | 0.74 (0.74–0.75) | 1.04 (1.04–1.05) | 1.01 (1.00–1.02) | 0.71 (0.70–0.71) | 0.67 (0.66–0.67) | 0.75 (0.74–0.77) | 0.83 (0.82–0.83) |
7.1–14.0 g/d | 0.98 (0.97–1.00) | 1.29 (1.27–1.31) | 1.39 (1.37–1.41) | 0.61 (0.60–0.62) | 0.92 (0.90–0.93) | 1.03 (0.99–1.07) | 1.05 (1.03–1.13) |
14.1–28.0 g/d | 1.08 (1.06–1.10) | 1.46 (1.43–1.48) | 1.68 (1.65–1.71) | 0.50 (0.49–0.51) | 1.17 (1.15–1.20) | 1.03 (0.99–1.08) | 1.11 (1.10–1.25) |
≥28 g/d | 1.25 (1.22–1.27) | 1.64 (1.60–1.67) | 2.01 (1.97–2.05) | 0.45 (0.44–0.46) | 1.49 (1.46–1.52) | 1.20 (1.14–1.27) | 1.23 (1.20–1.25) |
p-value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Age 40–64 | |||||||
Nondrinkers | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
≤7.0 g/d | 0.94 (0.94–0.95) | 1.04 (1.04–1.04) | 1.06 (1.06–1.07) | 0.68 (0.68–0.68) | 0.83 (0.82–0.83) | 0.82 (0.81–0.83) | 0.93 (0.93–0.94) |
7.1–14.0 g/d | 1.25 (1.24–1.26) | 1.33 (1.32–1.34) | 1.43 (1.42–1.44) | 0.60 (0.60–0.60) | 1.00 (0.99–1.01) | 1.06 (1.05–1.08) | 1.15 (1.14–1.16) |
14.1–28.0 g/d | 1.43 (1.41–1.44) | 1.54 (1.52–1.56) | 1.76 (1.74–1.77) | 0.57 (0.57–0.58) | 1.27 (1.16–1.19) | 1.21 (1.19–1.23) | 1.25 (1.23–1.26) |
≥28 g/d | 1.53 (1.51–1.56) | 1.71 (1.68–1.73) | 1.95 (1.92–1.98) | 0.56 (0.55–0.57) | 1.36 (1.34–1.38) | 1.34 (1.31–1.37) | 1.24 (1.22–1.26) |
p-value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Age ≥ 65 | |||||||
Nondrinkers | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
≤7.0 g/d | 1.06 (1.04–07) | 0.94 (0.932–0.95) | 1.00 (0.99–1.02) | 0.71 (0.70–0.72) | 0.84 (0.83–0.85) | 0.85 (0.84–0.86) | 1.05 (1.03–1.06) |
7.1–14.0 g/d | 1.22 (1.18–1.26) | 1.12 (1.08–1.15) | 1.20 (1.16–1.25) | 0.60 (0.58–0.62) | 0.82 (0.79–0.85) | 0.91 (0.88–0.94) | 1.15 (1.11–1.19) |
14.1–28.0 g/d | 1.27 (1.22–1.26) | 1.17 (1.12–1.22) | 1.30 (1.23–1.36) | 0.53 (0.51–0.55) | 0.82 (0.79–0.86) | 0.91 (0.87–0.95) | 1.17 (1.12–1.22) |
≥28 g/d | 1.25 (1.18–1.34) | 1.25 (1.17–1.33) | 1.31 (1.22–1.41) | 0.46 (0.43–0.49) | 0.79 (0.75–0.85) | 0.85 (0.80–0.91) | 1.02 (0.96–1.09) |
p-value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Park, E.J.; Shin, H.J.; Kim, S.S.; Kim, K.E.; Kim, S.H.; Kim, Y.R.; Chung, K.M.; Han, K.D. The Effect of Alcohol Drinking on Metabolic Syndrome and Obesity in Koreans: Big Data Analysis. Int. J. Environ. Res. Public Health 2022, 19, 4949. https://doi.org/10.3390/ijerph19094949
Park EJ, Shin HJ, Kim SS, Kim KE, Kim SH, Kim YR, Chung KM, Han KD. The Effect of Alcohol Drinking on Metabolic Syndrome and Obesity in Koreans: Big Data Analysis. International Journal of Environmental Research and Public Health. 2022; 19(9):4949. https://doi.org/10.3390/ijerph19094949
Chicago/Turabian StylePark, Eun Jung, Hye Jung Shin, Sung Soo Kim, Ki Eun Kim, Sun Hyun Kim, Youl Ri Kim, Kyong Mee Chung, and Kyung Do Han. 2022. "The Effect of Alcohol Drinking on Metabolic Syndrome and Obesity in Koreans: Big Data Analysis" International Journal of Environmental Research and Public Health 19, no. 9: 4949. https://doi.org/10.3390/ijerph19094949
APA StylePark, E. J., Shin, H. J., Kim, S. S., Kim, K. E., Kim, S. H., Kim, Y. R., Chung, K. M., & Han, K. D. (2022). The Effect of Alcohol Drinking on Metabolic Syndrome and Obesity in Koreans: Big Data Analysis. International Journal of Environmental Research and Public Health, 19(9), 4949. https://doi.org/10.3390/ijerph19094949